Effects of fish oil supplementation on learning and behaviour of children from Australian Indigenous remote community schools: A randomised controlled trial

被引:43
|
作者
Parletta, Natalie [1 ]
Cooper, Patrick [2 ]
Gent, Debra N. [1 ]
Petkov, John [3 ]
O'Dea, Kerin [1 ]
机构
[1] Univ S Australia, Sansom Inst Hlth Res, Sch Populat Hlth, Adelaide, SA 5001, Australia
[2] Northern Terr Dept Educ & Training, Katherine, NT, Australia
[3] Univ S Australia, Sansom Inst Hlth Res, Hlth & Use Time Grp, Adelaide, SA 5001, Australia
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 2013年 / 89卷 / 2-3期
基金
澳大利亚国家健康与医学研究理事会;
关键词
Omega-3 fatty acids; Indigenous children; Cognition; Learning; Behaviour; School; POLYUNSATURATED FATTY-ACIDS; NERVOUS-SYSTEM; DOCOSAHEXAENOIC ACID; EARLY MALNUTRITION; DIETARY REQUIREMENTS; BRAIN; HEALTH; OMEGA-3-FATTY-ACIDS; ATTENTION; DISORDER;
D O I
10.1016/j.plefa.2013.05.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Omega-3 fatty acids are essential for brain function. We recruited 409 children aged 3-13 years (M=8.27, SD=2.17) for a randomised controlled trial supplementing with placebo or fish oil capsules (providing 750 mg docosahexaenoic plus eicosapentaenoic acids, and 60 mg gamma linolenic acid/school day) for 20 school weeks (Phase 1) followed by one-way crossover to fish oil (Phase 2). Children undertook assessments of reading, spelling and non-verbal cognitive development (Draw-A-Person) at baseline, 20 and 40 weeks. Teachers completed Conners Behaviour Rating Scales (CBRS). The treatment group showed improvements in Draw-A-Person compared with the placebo during Phase 1 (p = 0.029), with strongest effects in Indigenous 7-12 year olds (p = 0.008). The placebo group showed significant within-group improvements after switching to treatment (p < 0.001). There was no treatment effect for reading or spelling, and CBRS data were unable to be analysed. These findings may be understood in the context that sustained school attendance and nutrition interact to produce school-related achievement. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:71 / 79
页数:9
相关论文
共 41 条
  • [41] 10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial
    Oguoma, Victor M.
    Wilson, Nicole
    Mulholland, Kim
    Santosham, Mathuram
    Torzillo, Paul
    McIntyre, Peter
    Smith-Vaughan, Heidi
    Balloch, Anne
    Chatfield, Mark
    Lehmann, Deborah
    Binks, Michael J.
    Chang, Anne
    Carapetis, Jonathan
    Krause, Vicki
    Andrews, Ross
    Snelling, Tom
    Licciardi, Paul
    Morris, Peter
    Leach, Amanda Jane
    BMJ OPEN, 2020, 10 (05):